The critical role of VEGFA in tumor angiogenesis was further validated by its association with poorer prognosis in NSCLC patients, as revealed by Kaplan–Meier survival analysis involving 2166 lung cancer patients (kmplot.com). Here, VEGFA is linked to lung carcinoma.